DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Navelbine (Vinorelbine) - Febrile Neutropenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Febrile Neutropenia (10)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Navelbine (Vinorelbine) where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Navelbine side effects in 64 year old female

Reported by a individual with unspecified qualification from Italy on 2012-07-24

Patient: 64 year old female

Reactions: Diarrhoea, Febrile Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Navelbine
    Dosage: 37.5 mg, unk, iv
    Indication: Lung Neoplasm Malignant
    Start date: 2011-06-08
    End date: 2011-06-15

Cisplatin
    Dosage: 40 mg unk, iv
    Indication: Lung Neoplasm Malignant
    Start date: 2011-06-08
    End date: 2011-06-09

Other drugs received by patient: Glutathione Sodiuim; Desamethasone Fost



Possible Navelbine side effects in 64 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-03

Patient: 64 year old female

Reactions: Diarrhoea, Febrile Neutropenia, RED Blood Cell Sedimentation Rate Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Navelbine
    Dosage: 37.5 mg unk iv
    Indication: Lung Neoplasm Malignant
    Start date: 2011-06-08
    End date: 2011-06-15

Cisplatin
    Dosage: 40 mg unk iv
    Indication: Lung Neoplasm Malignant
    Start date: 2011-06-08
    End date: 2011-06-09

Other drugs received by patient: Glutathione Sodium; Desametasone Fosf



Possible Navelbine side effects in 64 year old female

Reported by a physician from Italy on 2012-06-27

Patient: 64 year old female

Reactions: Diarrhoea, Febrile Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 50mg/100ml (cyclical)
    Indication: Lung Adenocarcinoma
    Start date: 2011-06-08
    End date: 2011-06-09

Navelbine
    Dosage: 37.5 (10 mg/ml,cyclical)
    Indication: Lung Adenocarcinoma
    Start date: 2011-06-08
    End date: 2011-06-15

Other drugs received by patient: Desametasone Fosfato Hospira; Glutatione Sodico



Possible Navelbine side effects in 14 year old female

Reported by a physician from United States on 2012-06-07

Patient: 14 year old female, weighing 55.0 kg (121.0 pounds)

Reactions: Atelectasis, Hypotension, Pleural Effusion, Febrile Neutropenia, Hypoxia, Pneumonitis, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Temsirolimus
    Dosage: days 1, 8 and 15 over 30-60 minutes
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-14
    End date: 2012-02-28

Cyclophosphamide
    Dosage: day 1 over 30-60 minutes
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-14
    End date: 2012-02-14

Navelbine
    Dosage: days 1 and 8, over 6-10 minutes
    Indication: Rhabdomyosarcoma
    Start date: 2012-02-01
    End date: 2012-02-21



Possible Navelbine side effects in female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-06

Patient: female, weighing 12.7 kg (27.9 pounds)

Reactions: Mucosal Inflammation, Fungaemia, Febrile Neutropenia, Epistaxis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ifosfamide
    Dosage: dadys 1 and 2
    Indication: Sarcoma Metastatic
    Start date: 2011-07-12

Mesna
    Start date: 2011-09-21

Mesna

Mesna
    Indication: Sarcoma Metastatic
    Start date: 2011-07-12

Cyclophosphamide
    Dosage: 11 mg
    Administration route: Oral
    Indication: Rhabdomyosarcoma
    Start date: 2012-03-01

Doxorubicin HCL
    Dosage: days 1 and 2
    Indication: Sarcoma Metastatic
    Start date: 2011-07-12

Dactinomycin
    Dosage: day 1 of cycle
    Indication: Sarcoma Metastatic
    Start date: 2011-07-12

Vincristine
    Dosage: days 1, 8 and 15 of cycle
    Indication: Sarcoma Metastatic
    Start date: 2011-07-12

Bevacizumab
    Indication: Sarcoma Metastatic
    Start date: 2011-07-12

Navelbine
    Indication: Rhabdomyosarcoma
    Start date: 2012-03-01

Other drugs received by patient: Ondansetron; Ondansetron; Levomepromazine; Docusate; Gentamycin Sulfate; Piperacillin and Tazobactam; Ondansetron; Neupogen; Levomepromazine; Docusate; Fluconazole; Docusate; Dihydrocodeine Bitartrate INJ; Ondansetron; Movicol / 01625101 /; Movicol / 01625101 /; Neupogen; Acetaminophen; Morphine; Movicol / 01625101 /; Cotrim



Possible Navelbine side effects in female

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-05-29

Patient: female, weighing 57.6 kg (126.7 pounds)

Reactions: Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Exemestane
    Dosage: 25 mg, qd
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-10-19
    End date: 2010-11-30

Placebo
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-10-19
    End date: 2010-11-30

Fluorouracil
    Dosage: 750 mg, 2/month
    Indication: Breast Cancer
    Start date: 2010-11-30
    End date: 2010-12-07

Blinded NO Treatment Received
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-10-19
    End date: 2010-11-30

Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-10-19
    End date: 2010-11-30

Navelbine
    Dosage: 35 mg, 4/month
    Indication: Breast Cancer
    Start date: 2010-11-30
    End date: 2010-12-07

Other drugs received by patient: Ecomer; Bisoprolol Fumarate



Possible Navelbine side effects in 69 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-23

Patient: 69 year old female, weighing 57.1 kg (125.6 pounds)

Reactions: Febrile Neutropenia, Neutropenia, Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Navelbine



Possible Navelbine side effects in 67 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-04-02

Patient: 67 year old female

Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Haematocrit Decreased, RED Blood Cell Count Decreased, Febrile Neutropenia, Mean Cell Volume Increased, Pneumonitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 230 mg iv
    Indication: Lung Adenocarcinoma Metastatic
    Start date: 2010-03-01
    End date: 2010-07-15

Navelbine
    Dosage: 25 mg iv
    Indication: Lung Adenocarcinoma Metastatic
    Start date: 2010-03-01
    End date: 2010-07-25



Possible Navelbine side effects in 52 year old female

Reported by a health professional (non-physician/pharmacist) from Israel on 2012-02-06

Patient: 52 year old female

Reactions: Dyspnoea, Rales, Wheezing, Febrile Neutropenia, Pulmonary Oedema, Pleural Effusion, Tachypnoea, Oxygen Saturation Decreased

Drug(s) suspected as cause:
Navelbine



Possible Navelbine side effects in 64 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-12-29

Patient: 64 year old female

Reactions: Confusional State, Abdominal Pain, Diarrhoea, Febrile Neutropenia, Muscle Spasms, Haematotoxicity, Infection

Drug(s) suspected as cause:
Navelbine
    Dosage: 45 mg
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-09-12

Cisplatin
    Dosage: 144 mg
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-09-12

Cisplatin
    Dosage: 146 mg
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-09-12

Navelbine
    Dosage: 45 mg
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-09-12

Cisplatin
    Dosage: 146 mg
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-08-18

Navelbine
    Dosage: 46 mg, iv
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-09-12

Navelbine
    Dosage: 45 mg, iv
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-08-18

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017